The Fed's hawkish signal sparked gold jitters — but analysts see support for the precious metal in 2025
Trump tariff proposals and a more hawkish Fed add to the downside risk for gold… But we expect non-traditional factors to be ...
GigaOm Sonar for Vector Databases Positions Vespa as a Leader and Forward Mover For the Second Consecutive Year
Vespa.ai, the creator of a leading platform for building and deploying large-scale, real-time AI applications powered by big data, today announced its recognition as a Leader and Forward Mover in the ...
Armed robbery in Revesby5h
Cook Govt Boosts WA TAFE Colleges Funding
The investment supports training demand and emerging industry needs, which will help students, apprentices and trainees to become job ready. As stated by Training and Workforce Development Minister ...
FierceBiotech21h
Ring lays off nearly half of staff, CEO to exit in new year
Flagship CEO-partner and Ring CEO Tuyen Ong, M.D., will also be shifting to an advisory role in the new year, according to ...
MarketVector™-GammaRoad U.S. Equity Strategy Index Celebrates One-Year Milestone
MarketVector IndexesTM ("MarketVector"), in collaboration with GammaRoad Capital Partners, celebrates the one-year anniversary of the MarketVectorTM-GammaRoad U.S. Equity Strategy Index (MVGMMA). The ...
How Higher Education Can Prepare To Implement GenAI For Student Inquiries
How can institutions measure their GenAI readiness for self-service, and which options can help them prepare for this ...
PharmiWeb3d
ViroCell Biologics expands U.S. business development team with two new appointments
ViroCell Biologics (“ViroCell” or the “Company”), a cell and gene therapy (“CGT”) contract development and manufacturing organization (“CDMO”) specializing in GMP viral vector manufacturing for ...
How Much Faking Is Acceptable During A Job Interview?
Despite repeated suggestions that we should "just be ourselves" during job interviews, it is clear that "faking good" and ...
PharmiWeb6d
AGC Biologics to Manufacture LVV for CAR-T Therapy Approved by FDA for Autolus Therapeutics’ AUCATZYL(R)
CDMO's Cell and Gene Center of Excellence Achieves fifth commercial viral vector product approval, and second overall from FDA in 2024 SEATTLE, WA and MILAN, ITALY / ACCESSWIRE / December 12, 2024 / ...